Findings

What do systematic reviews say?

2 questions · 2 findings · 2 reviews · Lung Cancer

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 1 · 50%

TG4010 added to chemotherapy vs chemotherapy alone

Health‐related quality of life · People with advanced non‐small cell lung cancer

The review found no eligible studies for this question.

1 finding from 1 review

Therapeutic vaccines for advanced non‐small cell lung cancer 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

ALK inhibitor vs any cytotoxic chemotherapy

Health‐related quality of life: time to deterioration in composite endpoint (cough, dyspnoea, and chest pain) · advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer

ALK inhibitor leads to lower health‐related quality of life: time to deterioration in composite… compared with any cytotoxic chemotherapy (high certainty).

1 finding from 1 review

Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer 2022 · Cochrane Headline outcomes only
HR 0.52 [0.44, 0.6]
5 studies · 1504 participants
High